Yasmin Pulmonary Embolism Lawsuit Transferred to Multidistrict Litigation: Now, AttorneyOne Can Provide Advice
San Diego, CA (PRWEB) September 16, 2013 -- AttorneyOne.com, a recognized authority on law, updated the website recently and they are now actively providing expert opinion in view of the recent news on Yasmin Side Effect lawsuits.
On July 25, a Yasmin lawsuit alleging pulmonary embolism (case no. 3:2013cv20020, Illinois Southern District Court) was transferred to the Yasmin Multiditrict Litigation (MDL 2100, Southern District of Illinois). Yasmin, which was approved by the FDA in 2001, and its sister drug Yaz, which was approved in 2006, are oral contraceptives that combine estrogen and a fourth generation progestin, drospirenone, to prevent pregnancy. Yasmin and Yaz are manufactured by Bayer Healthcare Pharmaceuticals. In the lawsuit, the plaintiff claims that she started taking Yasmin and Yaz and she suffered pulmonary embolism from her exposure to these drugs.
According to Health Canada documents released on June 11, Yasmin and Yaz have been linked to the deaths of at least 23 Canadian women (Vancouver Sun, "Yaz and Yasmin birth control pills linked to 23 deaths, say Health Canada documents", June 13). The report includes about 600 adverse reactions among women taking Yasmin and Yaz between 2007 and Feb. 28, 2013.
Taking into consideration the latest developments, AttorneyOne.com updated the website and, now, can actively provide an expert opinion including how to get in contact with legal counsel easily and inexpensively in case of alleged Yasmin severe complications. Sean Burke, director of Media Relations at AttorneyOne.com, adds that the relevant information illustrates that people continue to file Yasmin and Yaz lawsuits. "For that reason", he continues, "our focus should squarely fall on getting the word out and assisting people in finding the right legal assistance.”
A new study, published in the Annals of Noninvasive Electrocardiology on May 3*, revealed that fourth generation oral contraceptives (incl. Yasmin) are linked to heart risk at a higher extent than earlier generation contraceptives. According to the study, fourth-generation oral contraceptives have a lengthening effect on the QTc when prolonged corrected QT (QTc) interval is a marker for an increased risk of sudden cardiac death.
AttorneyOne.com has further information on Yasmin lawsuits including how to get in contact with legal counsel.
Headquartered in San Diego, CA Attorney One was founded in 2004 and is not a law firm. They offer a nationwide legal service which helps consumers find the best representation for their legal needs. You can learn more about Attorney One at our website http://www.attorneyone.com. You can also find us on Facebook at http://www.facebook.com/AttorneyOne. Checkout earlier news from us at http://www.prweb.com/releases/2013/9/prweb11119169.htm
- onlinelibrary.wiley.com/doi/10.1111/anec.12050/abstract
Sean Burke, Attorney One, http://www.attorneyone.com/fosamax/, 1-877-230-7343, [email protected]
Share this article